Related Experiment Videos

[Expression and differential diagnostic value of serum microRNA for invasive pulmonary aspergillosis]

Z N Wen1, Z G Ling, Y Huang

  • 1Department of Respiratory Medicine, Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou 545005, China.

Insights

Serum miR-21 levels are elevated in invasive pulmonary aspergillosis (IPA) and lung cancer patients. Combining miR-21 with galactomannan and beta-D-glucan tests significantly improves IPA diagnosis.

Area of Science:

  • Biochemistry
  • Medical Diagnostics
  • Molecular Biology

Background:

  • Invasive pulmonary aspergillosis (IPA) poses a diagnostic challenge.
  • Biomarkers are crucial for early and accurate detection of IPA.

Purpose of the Study:

  • To investigate the diagnostic value of serum miR-21 for invasive pulmonary aspergillosis (IPA).
  • To evaluate the combined diagnostic performance of miR-21 with galactomannan (GM) and (1,3)-beta-D-glucan (G) tests.

Main Methods:

  • Serum samples from IPA patients, pulmonary tuberculosis, lung cancer patients, and healthy controls were analyzed.
  • Levels of miR-21, GM, and G tests were measured.
  • Logistic regression and ROC curve analyses were employed.

Main Results:

  • Serum miR-21 levels were significantly elevated in IPA and lung cancer patients compared to healthy controls and tuberculosis patients.
  • Serum miR-21 demonstrated good diagnostic accuracy for IPA.
  • Combining miR-21 with G and GM tests markedly improved the diagnostic efficiency for IPA, especially in differentiating it from tuberculosis and lung cancer.

Conclusions:

  • Serum miR-21 is a potential independent diagnostic marker for IPA.
  • The combination of miR-21 with GM and G tests offers superior diagnostic performance for IPA.

Related Concept Videos